Regeneron Pharmaceuticals, Inc.
METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING RHEUMATOID ARTHRITIS
Last updated:
Abstract:
Disclosed herein are methods for treating subjects having rheumatoid arthritis (RA) with a human anti-interleukin 6 (IL-6) antibody, or antigen-binding portion thereof.
Status:
Application
Type:
Utility
Filling date:
28 Aug 2019
Issue date:
2 Apr 2020